Please Wait
Applying Filters...
menu
    • menu
    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Brincidofovir

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NanoViricides Nears Completion of MPox Clade I Trial Design
    NanoViricides Nears Completion of MPox Clade I Trial Design

    14 Jul 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/adaptive-clinical-protocol-design-for-phase-ii-mpox-clade-i-treatment-1048280

    ACCESSWIRE
    14 Jul 2025
    Share Share
    Emergent BioSolutions Executes Contract Options For TEMBEXA
    Emergent BioSolutions Executes Contract Options For TEMBEXA

    26 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/26/2953776/33240/en/Emergent-BioSolutions-Announces-the-Execution-of-Contract-Options-Valued-at-67-4-Million-to-Procure-Additional-TEMBEXA-brincidofovir-to-Support-National-Preparedness-Efforts.html

    GLOBENEWSWIRE
    26 Sep 2024
    Share Share
    Emergent closes on buying smallpox drug Tembexa from Chimerix
    Emergent closes on buying smallpox drug Tembexa from Chimerix

    28 Sep 2022

    // Tyler Patchen ENDPTS

    https://endpts.com/emergent-closes-on-buying-smallpox-drug-tembexa-from-chimerix-with-a-238m-payment/

    Tyler Patchen ENDPTS
    28 Sep 2022
    Share Share
    Emergent acquires global rights for oral smallpox antiviral from Chimerix
    Emergent acquires global rights for oral smallpox antiviral from Chimerix

    27 Sep 2022

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/emergent-smallpox-antiviral/

    PHARMACEUTICAL-TECHNOLOGY
    27 Sep 2022
    Share Share
    Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3M
    Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3M

    24 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/24/2468864/25619/en/Chimerix-Announces-TEMBEXA-Procurement-Agreement-for-Approximately-25-3-Million-with-Public-Health-Agency-of-Canada.html

    GLOBENEWSWIRE
    24 Jun 2022
    Share Share
    Emergent adds another arrow to its medical ountermeasures quiver
    Emergent adds another arrow to its medical ountermeasures quiver

    16 May 2022

    // Fraiser Kansteiner FIERCEPHARMA

    https://www.fiercepharma.com/pharma/emergent-beefs-countermeasure-repertoire-325m-deal-chimerixs-smallpox-newcomer-tembexa

    Fraiser Kansteiner FIERCEPHARMA
    16 May 2022
    Share Share